The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Open accessAbstract
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the brains of individuals with AD and preclinical AD (i.e., evidence of Aβ and tau deposition in the brain without any clinical manifestation of the disease), as well as patients with MCI (a mild clinical impairment with no proof of underlying pathology with biomarkers), many oxidative damage products are measured, and numerous investigations have pointed to OS as a key and early player in the”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the AD brain, mitochondria can be sources of ROS and also the target of OS, especially mitochondrial DNA (mtDNA) is susceptible to oxidative damage [19,53,63].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“Oxidative damage to RNA in EC, hippocampus, subiculum, and temporal neocortex of subjects with AD has been described. The levels of 8-OHdG increase early before pathological changes occur, and this can explain that the selective vulnerability of neurons in the EC during AD may be related to the vulnerability of these particular neurons to oxidative damage [19].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Research works printed but not linked: 2
- Smith, 1998, ApoE: Isoform specific antioxidant activity [abstract], Neurobiol Aging, 19, S222
- Nunomura, 2000, Increasing amyloid ß 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease [abstract], Brain pathol, 10, 783
Cited by
Sorted by citations
Items 301–400 of 1,005
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Self-citationMitochondria as ATP consumers in cellular pathology
Chinopoulos, C., & Ádám‐Vizi, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.008 · Cited by 147
Sajdel, E. M., Xu, M. Q., McGinnis, W. R., & Koibuchi, N. (2010) · The Cerebellum · doi:10.1007/s12311-010-0223-4 · Cited by 147
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
Kerr, F., Sofola-Adesakin, O., Ivanov, D. K., Gatliff, J., Perez‐Nievas, B. G., Bertrand, H. C., Martinez, P., Callard, R., Snoeren, I., Cochemé, H. M., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006593 · Cited by 147
Hung, C. H.-L., Cheng, S. S., Cheung, Y.-T., Wuwongse, S., Zhang, N. Q., Ho, J. Y. S., Lee, S. M., & Chang, R. C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.010 · Cited by 147
Objective measurement of sleep in mild cognitive impairment: A systematic review and meta-analysis
D'Rozario, A. L., Chapman, J. L., Phillips, C. L., Palmer, J. R., Hoyos, C. M., Mowszowski, L., Duffy, S. L., Marshall, N. S., Benca, R. M., Mander, B. A., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101308 · Cited by 147
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells
Gómez‐Ramos, A., Díaz‐Nido, J., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10525 · Cited by 146
Self-citationOxidative Imbalance in Alzheimer's Disease
Zhu, X., Lee, H., Casadesús, G., Ávila, J., Drew, K. L., Perry, G. L., & Smith, M. A. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:205 · Cited by 146
Self-citationLiu, J., Yin, F., Zheng, X., Jing, J., & Hu, Y. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.021 · Cited by 145
Dong, Y., Kataoka, K., Tokutomi, Y., Nako, H., Nakamura, T., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Ogawa, H., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-182873 · Cited by 145
Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model
Kim, K.-S., Kim, H. S., Park, J.-M., Kim, H. W., Park, M., Lee, H., Lim, D. S., Lee, T. H., Chopp, M., & Moon, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.029 · Cited by 144
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
Billingsley, K. J., Barbosa, I. A., Bandrés‐Ciga, S., Quinn, J. P., Bubb, V. J., Deshpande, C., Botía, J. A., Reynolds, R. H., Zhang, D., Simpson, M. A., et al. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0080-x · Cited by 144
Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia
Puertas, M. C., Martı́nez-Martos, J. M., Cobo, M., Carrera-González, M. P., Mayas, M. D., & Ramı́rez-Expósito, M. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.019 · Cited by 143
Chan, K., Lam, K. S. L., Cheng, O.-Y., Kwan, J., Ho, P. W., Cheng, K. K. Y., Chung, S. K., Ho, J. W.-M., Guo, V. Y., & Xu, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052354 · Cited by 143
Keating, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04997.x · Cited by 143
Villavicencio-Tejo, F., & Quintanilla, R. A. (2021) · Antioxidants · doi:10.3390/antiox10071069 · Cited by 143
Atwood, C., Martins, R. N., Smith, M. A., & Perry, G. L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00070-0 · Cited by 142
Self-citationAmyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 142
Self-citationThe link between altered cholesterol metabolism and Alzheimer's disease
Gamba, P., Testa, G., Sottero, B., Gargiulo, S., Poli, G., & Leonarduzzi, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06513.x · Cited by 141
Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
Pretorius, E., & Kell, D. B. (2014) · Integrative Biology · doi:10.1039/c4ib00025k · Cited by 141
Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
Sharma, C., & Kim, S. R. (2021) · Antioxidants · doi:10.3390/antiox10081231 · Cited by 145
Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease
Milton, N. G. N. (2004) · Drugs & Aging · doi:10.2165/00002512-200421020-00002 · Cited by 141
Abolhassani, N., Leon, J., Sheng, Z., Oka, S., Hamasaki, H., Iwaki, T., & Nakabeppu, Y. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.005 · Cited by 140
Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 140
Liu, P., Zhang, T., Chen, Q., Li, C., Chu, Y., Guo, Q., Zhang, Y., Zhou, W., Chen, H., Zhou, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100746 · Cited by 140
Hăncianu, M., Cioancă, O., Mihăşan, M., & Hriţcu, L. (2013) · Phytomedicine · doi:10.1016/j.phymed.2012.12.005 · Cited by 139
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease
McCord, M. C., & Aizenman, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00077 · Cited by 142
Iron: A Pathological Mediator of Alzheimer Disease?
Bishop, G. M., Robinson, S. R., Liu, Q., Perry, G. L., Atwood, C., & Smith, M. A. (2002) · Developmental Neuroscience · doi:10.1159/000065696 · Cited by 139
Self-citationNakajima, A., Aoyama, Y., Shin, E.-J., Nam, Y., Kim, H.-C., Nagai, T., Yokosuka, A., Mimaki, Y., Yokoi, T., Ohizumi, Y., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.028 · Cited by 138
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
Self-citationMitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
Bell, S., Barnes, K., Marco, M. D., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Venneri, A., & Mortiboys, H. (2021) · Biomedicines · doi:10.3390/biomedicines9010063 · Cited by 138
Cigarette Smoking Accelerated Brain Aging and Induced Pre-Alzheimer-Like Neuropathology in Rats
Ho, J. Y. S., Yang, X., Yeung, S., Chiu, K., Lau, C. G., Tsang, A. W.-T., Mak, J., & Chang, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036752 · Cited by 138
Kang, J. H., Cook, N. R., Manson, J. E., Buring, J. E., Albert, C. M., & Grodstein, F. (2009) · Circulation · doi:10.1161/circulationaha.108.816900 · Cited by 136
Pathophysiology of Alzheimer's Disease
Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 137
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
Nunomura, A., Chiba, S., Lippa, C. F., Cras, P. P., Kalaria, R. N., Takeda, A., Honda, K., Smith, M. A., & Perry, G. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.003 · Cited by 136
Self-citationLee, H., Casadesús, G., Zhu, X., Castellani, R. J., McShea, A., Perry, G. L., Petersen, R. B., Bajić, V., & Smith, M. A. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.013 · Cited by 136
Self-citationSlower Dynamics and Aged Mitochondria in Sporadic Alzheimer’s Disease
Martín-Maestro, P., Gargini, R., García, E., Perry, G. L., Ávila, J., & García‐Escudero, V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9302761 · Cited by 135
Self-citationOxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
Guglielmotto, M. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 135
Oxidative Stress, Antioxidants and Neurodegenerative Diseases
Casetta, I., Govoni, V., & Granieri, E. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054065729 · Cited by 135
Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease
Vardy, E. R. L. C., Catto, A. J., & Hooper, N. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.004 · Cited by 135
Sato, S., Tatebayashi, Y., Akagi, T., Chui, D.-H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202241200 · Cited by 135
Metal ions and oxidative protein modification in neurological disease.
Sayre, L. M., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · PubMed · Cited by 135
Self-citationNunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 134
Self-citationThrasivoulou, C., Soubeyre, V., Ridha, H., Giuliani, D., Giaroni, C., Michael, G. J., Saffrey, M. J., & Cowen, T. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00214.x · Cited by 134
Molecular and cellular pathophysiology of preclinical Alzheimer’s disease
Mufson, E. J., Ikonomović, M. D., Counts, S., Perez, S. E., Malek‐Ahmadi, M. H., Scheff, S. W., & Ginsberg, S. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.030 · Cited by 134
Mastroeni, D., Khdour, O. M., Delvaux, E., Nolz, J., Olsen, G., Berchtold, N. C., Cotman, C. W., Hecht, S. M., & Coleman, P. D. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.003 · Cited by 134
Alzheimer disease β-amyloid activity mimics cholesterol oxidase
Puglielli, L., Friedlich, A. L., Setchell, K. D. R., Nagano, S., Opazo, C., Cherny, R. A., Barnham, K. J., Wade, J. D., Melov, S., Kovacs, D. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23610 · Cited by 134
Aliev, G., Smith, M. A., Obrenovich, M. E., de la Torre, J. C., & Perry, G. L. (2003) · Neurotoxicity Research · doi:10.1007/bf03033159 · Cited by 134
Self-citationBolognesi, M. L., Banzi, R., Bartolini, M., Cavalli, A., Tarozzi, A., Andrisano, V., Minarini, A., Rosini, M., Tumiatti, V., Bergamini, C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070559a · Cited by 134
Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress
Eckert, A., Keil, U., Kressmann, S., Schindowski, K., Leutner, S., Leutz, S., & Müller, W. E. G. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40449 · Cited by 134
Oxidative Damage to RNA in Neurodegenerative Diseases
Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 133
Self-citationNeuropathology of Alzheimer disease: pathognomonic but not pathogenic
Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 133
Self-citationStudzinski, C. M., Christie, L., ARAUJO, J., Burnham, W. M., Head, E., Cotman, C. W., & Milgram, N. W. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.02.005 · Cited by 133
Peng, Y., Sun, J., Hon, S. M., Nylander, A., Xia, W., Feng, Y., Wang, X., & Lemere, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0340-10.2010 · Cited by 133
Gu, X., Sun, J., Li, S., Wu, X., & Li, L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.013 · Cited by 132
NADPH-oxidase activation and cognition in Alzheimer disease progression
Ansari, M. A., & Scheff, S. W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.025 · Cited by 131
“Excessive amounts of ROS can be extremely detrimental resulting in elevated levels of oxidative stress that appear to play an important role in numerous degenerative diseases including AD [8, 26, 27].”
BackgroundLate-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Sonntag, K.-C., Ryu, W.-I., Amirault, K. M., Healy, R. A., Siegel, A. J., McPhie, D. L., Forester, B., & Cohen, B. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14420-x · Cited by 131
Veronesi, B., Makwana, O., Pooler, M., & Chen, L. (2005) · Inhalation Toxicology · doi:10.1080/08958370590912888 · Cited by 131
Herculano, B., Tamura, M., Ohba, A., Shimatani, M., Kutsuna, N., & Hisatsune, T. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121324 · Cited by 130
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders
Perry, G. L., Sayre, L. M., Atwood, C., Castellani, R. J., Cash, A., Rottkamp, C. A., & Smith, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00006 · Cited by 130
Self-citationLi, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., Zhang, J., & Yang, J. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.020 · Cited by 129
NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models
COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
Yücel, Y. H., & Gupta, N. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01132-1 · Cited by 129
Mayeda, E. R., Whitmer, R. A., & Yaffe, K. S. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.08.021 · Cited by 129
Mitochondrial Dysfunction in Neural Injury
Zhao, X., Lu, M., Yuan, D., Xu, D.-E., Yao, P.-P., Ji, W., Chen, H., Liu, W., Yan, C.-X., Xia, Y., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00030 · Cited by 132
Alborixin clears amyloid-β by inducing autophagy through PTEN-mediated inhibition of the AKT pathway
Wani, A., Gupta, M., Ahmad, M. N., Shah, A. M., Ahsan, A. U., Qazi, P. H., Malik, F. A., Singh, G., Sharma, P. R., Kaddoumi, A., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596476 · Cited by 129
Oxidative Stress: The Old Enemy in Alzheimers Disease Pathophysiology
Moreira, P. I., Honda, K., Liu, Q., Santos, M. S., Oliveira, C. R., Aliev, G., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330537 · Cited by 129
Self-citationAlzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Liu, Q., Smith, M. A., Ávila, J., DeBernardis, J. F., Kansal, M. M., Takeda, A., Zhu, X., Nunomura, A., Honda, K., Moreira, P. I., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.005 · Cited by 129
Self-citationMitochondrial dynamics, a key executioner in neurodegenerative diseases
Panchal, K., & Tiwari, A. K. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.11.002 · Cited by 128
Epistasis in sporadic Alzheimer's disease
Combarros, O., Cortina‐Borja, M., Smith, A. D., & Lehmann, D. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.027 · Cited by 128
Vitamin E and neurodegenerative diseases
Ricciarelli, R., Argellati, F., Pronzato, M. A., & Domenicotti, C. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.01.004 · Cited by 128
Maki, R. A., Tyurin, V. A., Lyon, R. C., Hamilton, R. L., DeKosky, S. T., Kagan, V. E., & Reynolds, W. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807731200 · Cited by 127
General aspects of neurodegeneration
Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126
Walton, J. R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132204 · Cited by 126
Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 126
Marzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 126
Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126
Bonda, D., Mailankot, M., Stone, J. G., Garrett, M. R., Staniszewska, M. M., Castellani, R. J., Siedlak, S. L., Zhu, X., Lee, H., Perry, G. L., et al. (2010) · Redox Report · doi:10.1179/174329210x12650506623645 · Cited by 126
Self-citationAntioxidant Treatment in Alzheimer's Disease: Current State
Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:1:1 · Cited by 126
Quantification of oxidized RNAs in Alzheimer's disease
Shan, X., & Lin, C.-L. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.022 · Cited by 125
Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 125
Mitochondrial failures in Alzheimer's disease
Zhu, X., Smith, M. A., Perry, G. L., & Aliev, G. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900611 · Cited by 125
Self-citationBowen, R. L., Smith, M. A., Harris, P. L. R., Kubat, Z., Martins, R. N., Castellani, R. J., Perry, G. L., & Atwood, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10452 · Cited by 125
Self-citationA Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments
Gibson, G. E., & Shi, Q. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100336 · Cited by 124
Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain
Lovell, M. A., Soman, S., & Bradley, M. A. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.08.003 · Cited by 124
Abe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10349 · Cited by 124
Gamba, P., Leonarduzzi, G., Tamagno, E., Guglielmotto, M., Testa, G., Sottero, B., Gargiulo, S., Biasi, F., Mauro, A., Viña, J., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00681.x · Cited by 124
Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction
Sun, K., de Pablo, Y., Vincent, F., & Shah, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05616.x · Cited by 124
Cano, A., Turowski, P., Ettcheto, M., Duskey, J. T., Tosi, G., Sánchez-López, E., García, M. L., Camins, A., Souto, E. B., Ruiz, A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00864-x · Cited by 122
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 122
Free Superoxide is an Intermediate in the Production of H 2 O 2 by Copper(I)‐Aβ Peptide and O 2
Reybier, K., Ayala, S., Aliès, B., Rodrigues, J. V., Rodriguez, S. B., Penna, G. L., Collin, F., Gomes, C. M., Hureau, C., & Faller, P. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508597 · Cited by 122
Batkulwar, K., Godbole, R. K., Banarjee, R., Kassaar, O., Williams, R. J., & Kulkarni, M. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00410 · Cited by 122
Everett, J. L., Collingwood, J. F., Tjhin, V. T., Brooks, J., Lermyte, F., Plascencia‐Villa, G., Hands-Portman, I., Dobson, J., Perry, G. L., & Telling, N. D. (2018) · Nanoscale · doi:10.1039/c7nr06794a · Cited by 122
Self-citationŠalković‐Petrišić, M., Barilar, J. O., Grünblatt, E., Riederer, P. F., & Hoyer, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1184 · Cited by 122
Zuo, L., Hemmelgarn, B. T., Chuang, C., & Best, T. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/604658 · Cited by 122
Sarno, P. D., Shestopal, S. A., King, T. D., Zmijewska, A. A., Song, L., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212157200 · Cited by 121
Robson, K. J. H., Lehmann, D. J., Wimhurst, V. L. C., Livesey, K. J., Combrinck, M., Merryweather-Clarke, A. T., Warden, D. R., & Smith, A. D. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.015552 · Cited by 120
Young, M. L., & Franklin, J. L. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103409 · Cited by 120
Resting Cerebral Blood Flow After Exercise Training in Mild Cognitive Impairment
Alfini, A. J., Weiss, L. R., Nielson, K. A., Verber, M., & Smith, J. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180728 · Cited by 120
Metadata
- Authors
- Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., & Smith, M. A.
- Affiliations
- Asahikawa Medical University (JP)
- Case Western Reserve University (US)
- Takeda (Japan) (JP)
- Sensei Biotherapeutics (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Nunomura, Akihiko
- ORCID
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08
- Volume
- 60
- Issue
- 8
- Pages
- 759-767
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1542215809
- Cited by
- 1,885
- References
- 59
- Citations by year
- 2026: 46 · 2025: 31 · 2024: 52 · 2023: 61 · 2022: 80 · 2021: 98 · 2020: 86 · 2019: 82 · 2018: 69 · 2017: 73 · 2016: 70 · 2015: 83 · 2014: 86 · 2013: 86 · 2012: 104
- FWCI
- 33.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Asahikawa Medical University Collection and Research (Asahikawa Medical University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag009287-08, AG09287)
- Japan Society for the Promotion of Science (12670918)
- National Institute on Aging (AG-14249, R01AG014249, AG 09287)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, oxidative damage, 8-hydroxyguanosine, nitrotyrosine, amyloid plaques, neurofibrillary tangles, APOE ε4, disease progression, neurodegeneration, reactive oxygen species, RNA oxidation
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Guanosine, Heterozygote, Humans, Male, Middle Aged, Neurons, Tyrosine, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
